Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) EPS (Basic): 2011-2024

Historic EPS (Basic) for Veracyte (VCYT) over the last 14 years, with Dec 2024 value amounting to $0.32.

  • Veracyte's EPS (Basic) rose 20.00% to $0.24 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.39, marking a year-over-year increase of 400.00%. This contributed to the annual value of $0.32 for FY2024, which is 131.37% up from last year.
  • As of FY2024, Veracyte's EPS (Basic) stood at $0.32, which was up 131.37% from -$1.02 recorded in FY2023.
  • In the past 5 years, Veracyte's EPS (Basic) ranged from a high of $0.32 in FY2024 and a low of -$1.11 during FY2021.
  • In the last 3 years, Veracyte's EPS (Basic) had a median value of -$0.51 in 2022 and averaged -$0.40.
  • Its EPS (Basic) has fluctuated over the past 5 years, first plummeted by 144.44% in 2020, then soared by 131.37% in 2024.
  • Veracyte's EPS (Basic) (Yearly) stood at -$0.66 in 2020, then plummeted by 68.18% to -$1.11 in 2021, then spiked by 54.05% to -$0.51 in 2022, then tumbled by 100.00% to -$1.02 in 2023, then soared by 131.37% to $0.32 in 2024.